We aim to eliminate deaths and disease from congenital syphilis
THE PROBLEM
140,000
stillbirths
Every year congenital syphilis causes 140,000 stillbirths and 60,000 newborn deaths - this is entirely preventable.
60,000
newborn
deaths
Syphilis testing rates of mothers in low- and middle-income countries are low, with only 54% of pregnant women in sub-Saharan Africa tested, despite cost-effective tests and treatment.
THE SOLUTION
We support countries to screen pregnant women with rapid Syphilis/HIV dual tests, and treat syphilis-positive women with penicillin.
Treatment is very effective - Treating a pregnant woman leads to:
-
97% reduced risk of passing syphilis on to newborns
-
82% reduced risk of stillbirth
-
82% reduced risk of newborn death
TEAM
.png)
Keyur Doolabh
​
-
Medical doctor trained in Emergency Medicine
-
B. MedSc. in Bioethics
-
Multiple peer-reviewed publications
Nils Voelker
-
Former Pharma & Global Health Consultant
-
M. Sc. Health Economics
-
Track record in social impact entrepreneurship
​We graduated from Charity Entrepreneurship’s Incubation Program in late April 2023, and received a seed grant to start Healthy Futures Global.
We are a non-profit organization, operating under the tax exempt status of the United States of America, namely 501c3. Because of our non-profit / NGO status, we declare to have no conflict of interests to any of the manufacturers or suppliers that we are working with (e.g. on test kits and penicillin). Find more on that here.
SUBSCRIBE
Sign up for our newsletter to receive updates about our work, research, and job opportunities.